eClinical Solutions Market worth $ 16.36 billion by 2027 – Exclusive Report by Precedence Research

According to Precedence Research, during the forecast period of 2020 to 2027, the global eClinical solutions market is estimated to develop at a compound annual growth rate (CAGR) of 13.6%. The global eClinical solutions market was valued at USD 5.9 billion in 2019, and it is predicted to exceed USD 16.36 billion by 2027. The study investigates several elements and their consequences on the growth of the eClinical solutions market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1092

Growth Factor

Increase in the number of customers adopting eClinical solutions, rising Research and Development (R&D), and rise in government grants to authorize the clinical trials. These solutions are also used in clinical studies where electronic applications enabled with web tools are used to capture the real-time data from clinical trials that provide superior execution and escalate the eClinical solutions market growth.

Rising demand for clinical trials by biopharma and pharma companies boosts the industry demand. They offer services for large consumer base at low operating costs that again propel the eClinical solutions market growth. eClinical solutions also helps in organizing, tracking, and executing data from numerous geographical locations and also triggers the process of clinical development.

Factors such as real-time notifications, real-time reporting, real-time tracking, and configurable report building expected to augment the industry growth in the near future. In addition, eClinical solutions make electronic data capture, clinical data management, statistical programming, data conversion & standardization, and data reporting enormously easy that further drives the eClinical solutions market growth. These solutions also use products, technology, and services to offer clinical trials that reduce human errors and effectively manage large amount of data in real-time. Technological advancements in the eClinical solutions, globalization of clinical trials, enhancement in efficiency provided by eClinical solutions, and reduced costs are some of the main drivers of the eClinical solutions market.

Report Highlights

• In 2019, North America captured the highest market value share owing to rising prevalence of lifestyle with several diseases such as cardiac disorder and diabetes
• The Asia Pacific exhibits lucrative growth over the analysis period due to rising prevalence of chronic diseases such as cardiovascular conditions, cancer, and infectious diseases
• Electronic Clinical Outcome Assessment (eCOA) estimated to be the fastest growing product segment over the analysis period due to rising importance of high-quality clinical data
• By development phase, phase III segment lead the global market throughout the forecast period due to rising need for clinical data management software
• Phase I likely to execute promising growth during the analysis period owing to increased importance of these systems to analyze future outcomes
• Based on delivery mode, web-hosted solutions accounted maximum value share in 2019 due to its benefits that are usability, easy accessibility, and lower investments required
• Cloud-based solutions predicted to exhibit strong growth during the analysis period due to integrated features such as high accessibility, flexibility, and easy data backup
• CROs dominated the global market and expected to witness notable growth in the coming years owing to the rising concern of pharmaceutical companies to reduce their overall expenditure
• Pharmaceutical and biotechnology companies expected to witness prominent growth over the forecast period.

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1092

This report focuses on eClinical solutions market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall eClinical solutions market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of eClinical solutions, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of eClinical solutions has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the eClinical solutions market.

Some of the prominent players in the eClinical solutions market include:

• PAREXEL International
• Oracle Corp.
• Bioclinica
• Medidata Solution
• DATATRAK
• ERT Clinical
• CRF Health
• eClinicalWorks
• OmniComm Systems
• IBM Watson Health
• eClinical Solutions

Segments Covered in the Report

By Product

• EDC & CDMS
• eCOA
• Clinical Data Integration Platforms
• CTMS
• Safety Solutions
• RTSM
• Clinical Analytics platforms
• eTMF

By Development Phase

• Phase IV
• Phase III
• Phase II
• Phase I

By Delivery Mode

• Licensed Enterprise
• Web-hosted
• Cloud-based

By End-Use

• CROs
• Hospitals
• Academic Institutes
• Medical Device Manufacturers
• Pharma & Biotech Organizations

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global eClinical Solutions Market, By Product

7.1. eClinical Solutions Market, by Product Type, 2020-2027
7.1.1. EDC & CDMS
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. eCOA
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Clinical Data Integration Platforms
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. CTMS
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Safety Solutions
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. RTSM
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Clinical Analytics platforms
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. eTMF
7.1.8.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global eClinical Solutions Market, By Development Phase

8.1. eClinical Solutions Market, by Development Phase, 2020-2027
8.1.1. Phase IV
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Phase III
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Phase II
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Phase I
8.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global eClinical Solutions Market, By Delivery Mode

9.1. eClinical Solutions Market, by Delivery Mode, 2020-2027
9.1.1. Licensed Enterprise
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Web-hosted
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Cloud-based
9.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global eClinical Solutions Market, By End-Use

10.1. eClinical Solutions Market, by End-Use, 2020-2027
10.1.1. CROs
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Academic Institutes
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Medical Device Manufacturers
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Pharma & Biotech Organizations
10.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global eClinical Solutions Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End-Use (2016-2027)

Chapter 12. Company Profiles

12.1. PAREXEL International
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Oracle Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bioclinica
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medidata Solution
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. DATATRAK
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ERT Clinical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CRF Health
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. eClinicalWorks
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OmniComm Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. IBM Watson Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. eClinical Solutions
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1092

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com